Status:
COMPLETED
Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis
Lead Sponsor:
Keesler Air Force Base Medical Center
Conditions:
Subacromial Bursitis
Shoulder Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
It is currently unknown whether or not the improvement in pain and function related to a "steroid shot" for shoulder pain due to subacromial bursitis is important. This study seeks to determine whethe...
Detailed Description
Background: Subacromial bursitis is a common site for patients to report shoulder pain. In some patients it is refractory to conservative therapies such as physical therapy, acetaminophen, or NSAIDs. ...
Eligibility Criteria
Inclusion
- Age 18 years or older
- History and physical examination consistent with shoulder pain and subacromial bursitis
- At least 2 weeks of shoulder pain and subacromial bursitis
Exclusion
- Known allergies to Lidocaine, Marcaine, Methylprednisolone, and/or Triamcinolone
- History or examination suspicious for a humeral head fracture
- History or examination consistent with adhesive capsulitis (normal X-Ray of the shoulder but with less than 100 degrees of active or passive elevation of the arm, when raising the arm above the head to a maximum with passive external rotation being 50 degrees less than the unaffected side
- History or examination consistent with acute synovitis of the glenohumeral or acromioclavicular joint
- Any shoulder surgery involving the affected arm within the last 6 months
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT02242630
Start Date
September 1 2014
End Date
March 1 2016
Last Update
December 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Keesler Medical Center
Keesler Air Force Base, Mississippi, United States, 39534